# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.marijuanamoment.net/dea-appears-to-question-marijuanas-medical-value-despite-rescheduling-recommendation/
Canopy Growth confirms acquisitions of Wana and Jetty, enhancing its U.S. cannabis market strategy and operational synergies.
Following the recent move on the part of the DEA toward
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits ...